Marc J Claeys

Summary

Affiliation: University of Antwerp
Country: Belgium

Publications

  1. ncbi Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation
    Marc G Van der Planken
    Laboratory of Hematology and Hemostasis, Department of Clinical Pathology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium
    Thromb Res 111:159-64. 2003
  2. ncbi Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction
    Marc J Claeys
    Department of Cardiology, University Hospital Antwerp, Wilrijkstr 10 2650 Edegem, Belgium
    Arch Intern Med 171:544-9. 2011
  3. ncbi Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis
    Marc J Claeys
    Department of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Eur Heart J 26:567-75. 2005
  4. ncbi Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction
    Marc J Claeys
    Department of Cardiology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium
    Am J Cardiol 94:9-13. 2004
  5. ncbi Short-term effect of atorvastatin on ischaemic threshold in hypercholesterolaemic patients with stable ischaemic heart disease
    Marc J Claeys
    Cardiology, Hospital Brain l Alleud, Rue Wayez 35, 1420 Brain l Alleud, Belgium
    Acta Cardiol 59:269-74. 2004
  6. ncbi Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP
    Catherine M Moerenhout
    Department of Cardiology, University Hospital of Antwerp, Edegem, Belgium
    Am Heart J 159:434-8. 2010
  7. ncbi The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction
    Anne Vorlat
    Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium
    Acta Cardiol 66:281-5. 2011
  8. ncbi TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction
    Anne Vorlat
    University Hospital Antwerp, Belgium
    Acute Card Care 10:26-9. 2008
  9. ncbi Effect of folic acid on endothelial function following acute myocardial infarction
    An L Moens
    Department of Cardiology, University Hospital of Antwerp, Antwerp, Belgium
    Am J Cardiol 99:476-81. 2007
  10. ncbi Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation
    Anne Vorlat
    Department of Cardiology, Antwerp University Hospital, University of Antwerp, Wilrijkstraat 10, Wilrijk, Belgium
    J Heart Lung Transplant 31:579-84. 2012

Collaborators

Detail Information

Publications21

  1. ncbi Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation
    Marc G Van der Planken
    Laboratory of Hematology and Hemostasis, Department of Clinical Pathology, University Hospital Antwerp, Wilrijkstraat 10, 2650, Edegem, Belgium
    Thromb Res 111:159-64. 2003
    ..Whether such a short-term superiority of abciximab, as compared to loading dose clopidogrel, translates into an overall clinical benefit of thombotic and bleeding complications remains to be established in a randomized clinical trial...
  2. ncbi Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction
    Marc J Claeys
    Department of Cardiology, University Hospital Antwerp, Wilrijkstr 10 2650 Edegem, Belgium
    Arch Intern Med 171:544-9. 2011
    ..Modern thrombolysis may affect the previously observed mortality difference between primary percutaneous coronary intervention (PPCI) and thrombolysis...
  3. ncbi Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis
    Marc J Claeys
    Department of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Eur Heart J 26:567-75. 2005
    ..Whether further inhibition of platelet aggregation by a glycoprotein IIb/IIIa antagonist may provide an additional cardioprotection is unknown...
  4. ncbi Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction
    Marc J Claeys
    Department of Cardiology, University Hospital Antwerp, University of Antwerp, Antwerp, Belgium
    Am J Cardiol 94:9-13. 2004
    ..Adjunctive therapy with intracoronary infusion of adenosine during PCI prevents the occurrence of severe myocardial reperfusion injury and is associated with less infarct expansion...
  5. ncbi Short-term effect of atorvastatin on ischaemic threshold in hypercholesterolaemic patients with stable ischaemic heart disease
    Marc J Claeys
    Cardiology, Hospital Brain l Alleud, Rue Wayez 35, 1420 Brain l Alleud, Belgium
    Acta Cardiol 59:269-74. 2004
    ..This study was designed to determine the effect of 4 weeks' treatment with 80 mg atorvastatin daily on exercise-induced ischaemia in patients with stable ischaemic heart disease (IHD) receiving standard anti-anginal drug therapy...
  6. ncbi Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP
    Catherine M Moerenhout
    Department of Cardiology, University Hospital of Antwerp, Edegem, Belgium
    Am Heart J 159:434-8. 2010
    ..Early identification of nonresponders to clopidogrel may be important in identifying subgroups of patients that might be at risk for future thrombotic events...
  7. ncbi The determinants of B-type natriuretic peptide release in acute, non-ST-segment elevation myocardial infarction
    Anne Vorlat
    Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium
    Acta Cardiol 66:281-5. 2011
    ..B-type natriuretic peptide (BNP) is used to predict the clinical outcome of acute coronary syndromes, even in the absence of signs of cardiac failure. The triggers for BNP release have yet to be identified...
  8. ncbi TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction
    Anne Vorlat
    University Hospital Antwerp, Belgium
    Acute Card Care 10:26-9. 2008
    ..To determine the value of the TIMI risk score in the individual risk stratification of patients with unstable angina/non-ST segment elevation myocardial infarction (UA/NSTEMI)...
  9. ncbi Effect of folic acid on endothelial function following acute myocardial infarction
    An L Moens
    Department of Cardiology, University Hospital of Antwerp, Antwerp, Belgium
    Am J Cardiol 99:476-81. 2007
    ..Folic acid can be recommended to improve postinfarction endothelial dysfunction in patients with normo- and hyperhomocysteinemia...
  10. ncbi Donor B-type natriuretic peptide predicts early cardiac performance after heart transplantation
    Anne Vorlat
    Department of Cardiology, Antwerp University Hospital, University of Antwerp, Wilrijkstraat 10, Wilrijk, Belgium
    J Heart Lung Transplant 31:579-84. 2012
    ..We measured B-type natriuretic peptide (BNP) in heart donors and analyzed its value as a discriminator for early post-transplant cardiac performance...
  11. ncbi B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction
    Anne Vorlat
    Department of Cardiology, Antwerp University Hospital, Belgium
    Int J Cardiol 114:46-9. 2007
    ..B-type natriuretic peptide (BNP) is used as prognostic marker in acute coronary syndromes. It is unknown whether BNP reflects the amount of jeopardised myocardium in the initial phase of acute ST-elevation myocardial infarction (STEMI)...
  12. ncbi Systemic inflammation and reperfusion injury in patients with acute myocardial infarction
    Fien Blancke
    Department of Cardiology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium
    Mediators Inflamm 2005:385-9. 2005
    ..Our findings suggest that TNF-alpha is involved in the triggering and/or amplification of local inflammatory responses related to ischemia-reperfusion injury...
  13. ncbi Antiplatelet therapy for elective coronary stenting: a moving target
    Marc J Claeys
    Division of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Semin Vasc Med 3:415-8. 2003
    ....
  14. ncbi Quantitative coronary arteriography on digital flat-panel system
    Paul L Van Herck
    Department of Cardiology, Antwerp University Hospital, Edegem, Belgium
    Catheter Cardiovasc Interv 63:192-200. 2004
    ..001) and could only give values up to 70% for diameter stenosis. In conclusion, the FPAS can be considered more appropriate for assessing severe stenoses on digital flat-panel images...
  15. ncbi Depressed expression of MuRF1 and MAFbx in areas remote of recent myocardial infarction: a mechanism contributing to myocardial remodeling?
    Viviane M Conraads
    Department of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium
    Basic Res Cardiol 105:219-26. 2010
    ..Reduced expression of MuRF1 and MAFbx in the myocardium might permit hypertrophy, which is supported by the elevation of troponin I. A regulatory role of TNF-alpha needs to be confirmed in further experiments...
  16. ncbi Comparison of magnetic resonance imaging of aortic valve stenosis and aortic root to multimodality imaging for selection of transcatheter aortic valve implantation candidates
    Bernard P Paelinck
    Department of Cardiology, University Hospital, Antwerp, Belgium
    Am J Cardiol 108:92-8. 2011
    ..MRI and TEE provided similar and essential assessment of the aortic valve annulus dimensions, especially at the limits of the transcatheter aortic valve implantation range...
  17. ncbi Alternative access in transcatheter aortic valve implantation: brachiocephalic artery access
    Tine E Philipsen
    From the Departments of Cardiac Surgery and Cardiology, Antwerp University Hospital, Edegem, Belgium
    Innovations (Phila) 7:372-5. 2012
    ..No procedural or late complications were seen. If transfemoral, subclavian, and direct aortic accesses for TAVI are contraindicated, the direct brachiocephalic access seems to be a safe and feasible alternative...
  18. ncbi Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool?
    An L Moens
    Department of Cardiology, University of Antwerp, University Hospital of Antwerp, Wilrijkstraat 10, 2650 Antwerp, Belgium
    Chest 127:2254-63. 2005
    ..In this review article, the pathophysiology of FMD, based on reactive hyperemia, is extensively discussed. Furthermore, an overview is given of the actual clinical indications of FMD measurement...
  19. ncbi Influence of ionic and non-ionic radiographic contrast media on leukocyte adhesion molecules
    Guy L J Vermeiren
    Department of Intensive Care, University Hospital of Antwerp, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Mediators Inflamm 12:269-75. 2003
    ..This effect should be taken into account when performing leukocyte functional analysis of samples taken during angiography...
  20. ncbi Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
    Marc S Sabatine
    TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    N Engl J Med 352:1179-89. 2005
    ....
  21. ncbi High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury
    An L Moens
    Johns Hopkins Medical Institutions, Division of Cardiology, Baltimore, MD 21205, USA
    Circulation 117:1810-9. 2008
    ..Here, we tested whether FA reduces myocardial ischemic dysfunction and postreperfusion injury...